Literature DB >> 29376855

SORL1 Variants in Familial Alzheimer's Disease.

Estrella Gómez-Tortosa1, María Ruggiero1, Ma José Sainz1, Alberto Villarejo-Galende2, Cristina Prieto-Jurczynska3, Begoña Venegas Pérez3, Carlos Ordás3, Pablo Agüero1, Rosa Guerrero-López4, Julián Pérez-Pérez5.   

Abstract

The SORL1 gene encodes a protein involved in the amyloidogenic process, and its variants have been associated with Alzheimer's disease (AD) physiopathology. We screened for SORL1 variants in 124 familial (44 early- and 80 late-onset) dementia of Alzheimer type (DAT) cases. Nine potentially pathogenic changes (three not previously reported and six rare variants) were found in nine probands (7%). After screening the control population and siblings (presence in at least 1/200 controls and/or absence of segregation pattern), a causal relationship with the disease was considered unlikely in six variants and uncertain in one. The change Trp848Ter and a splice-site variant remained likely correlated with the disease. SORL1 mutations are present in 7% of our familial DAT cohort, though in most cases cannot be considered the direct cause of the disease.

Entities:  

Keywords:  Alzheimer’s disease; SORL1 gene; SORLA protein; familial; neurogenetics

Mesh:

Substances:

Year:  2018        PMID: 29376855     DOI: 10.3233/JAD-170590

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

Review 1.  LncRNAs as the Regulators of Brain Function and Therapeutic Targets for Alzheimer's Disease.

Authors:  Yuqing Liu; Xin Chen; Yutong Che; Hongli Li; Zheyu Zhang; Weijun Peng; Jingjing Yang
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

2.  HSPA12A targets the cytoplasmic domain and affects the trafficking of the Amyloid Precursor Protein receptor SorLA.

Authors:  Peder Madsen; Toke Jost Isaksen; Piotr Siupka; Andrea E Tóth; Mette Nyegaard; Camilla Gustafsen; Morten S Nielsen
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

3.  Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer's Disease Patients: Clinical, Neuroimaging and Neuropathological Findings.

Authors:  Maria Isabel Alvarez-Mora; Victor Antonio Blanco-Palmero; Juan Francisco Quesada-Espinosa; Ana Rosa Arteche-Lopez; Sara Llamas-Velasco; Carmen Palma Milla; Jose Miguel Lezana Rosales; Irene Gomez-Manjon; Aurelio Hernandez-Lain; Justino Jimenez Almonacid; Belén Gil-Fournier; Soraya Ramiro-León; Marta González-Sánchez; Alejandro Octavio Herrero-San Martín; David Andrés Pérez-Martínez; Estrella Gómez-Tortosa; Eva Carro; Fernando Bartolomé; Maria Jose Gomez-Rodriguez; María Teresa Sanchez-Calvin; Alberto Villarejo-Galende; Marta Moreno-Garcia
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

4.  Mutations in SORL1 and MTHFDL1 possibly contribute to the development of Alzheimer's disease in a multigenerational Colombian Family.

Authors:  Johanna Alexandra Tejada Moreno; Andrés Villegas Lanau; Lucia Madrigal Zapata; Ana Yulied Baena Pineda; Juan Velez Hernandez; Omer Campo Nieto; Alejandro Soto Ospina; Pedronel Araque Marín; Lavanya Rishishwar; Emily T Norris; Aroon T Chande; I King Jordan; Gabriel Bedoya Berrio
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.